Doorley Laura A, Meza-Perez Vanessa, Jones Sarah J, Rybak Jeffrey M
bioRxiv. 2025 Feb 15:2025.02.14.638356. doi: 10.1101/2025.02.14.638356.
Mutations in the ( ) β-glucan synthase gene ( ) altering S639 are frequently associated with clinical echinocandin resistance. However, the direct impact of these mutations remains uncharacterized. We have developed a novel optimized pisomal lasmid- nduced as9 (EPIC) gene-editing system capable of recyclable precision genome editing and demonstrate the contribution of mutation to echinocandin resistance.
The EPIC gene-editing system was generated for optimized use in , and modification was evaluated in 5 clades. Mutations leading to Fks1 and Fks1 were placed into echinocandin-susceptible and echinocandin-resistant isolates from Clade-III and -I, respectively, using the EPIC system. Echinocandin susceptibility was determined by CLSI broth microdilution, and cell wall abundance of chitin and β-glucan was assessed by staining with Calcofluor White (CFW) and Aniline Blue (AB).
The EPIC system was capable of targeted editing in isolates from 5 genetic clades and shown to be precise by confirmatory sequencing of 50 transformants. A single nucleotide change in resulting in either the S639F substitution or a silent synonymous mutation was introduced in an echinocandin-susceptible Clade-III isolate. Precision editing by the EPIC system was confirmed by whole genome sequencing. Subsequent susceptibility testing demonstrated introduction of the S639F mutation to increase resistance to echinocandins. Moreover, introduction of a wildtype Fks1 sequence to an echinocandin-resistant Clade-I clinical isolate, correcting the mutation, resulted in a restoration of echinocandin sensitivity. Evaluation of cell wall composition showed isolates or strains harboring to contain significantly elevated β-glucan and chitin content relative to isogenic comparators.
These data demonstrate the potential of our EPIC system in its ability to introduce single nucleotide substitutions in multiple clade backgrounds while revealing the direct impact of the S639F encoding mutation on echinocandin resistance.
β-葡聚糖合酶基因中改变S639的突变常与临床棘白菌素耐药性相关。然而,这些突变的直接影响仍未明确。我们开发了一种新型的优化的基于质粒的lasmid诱导的as9(EPIC)基因编辑系统,该系统能够进行可循环的精确基因组编辑,并证明了突变对棘白菌素耐药性的作用。
生成EPIC基因编辑系统以优化在中的使用,并在5个进化枝中评估修饰情况。使用EPIC系统将导致Fks1和Fks1的突变分别置于来自进化枝III和I的棘白菌素敏感和棘白菌素耐药分离株中。通过CLSI肉汤微量稀释法测定棘白菌素敏感性,并用荧光增白剂(CFW)和苯胺蓝(AB)染色评估几丁质和β-葡聚糖的细胞壁丰度。
EPIC系统能够在来自5个遗传进化枝的分离株中进行靶向编辑,并通过对50个转化体的验证性测序表明其精确性。在一个棘白菌素敏感的进化枝III分离株中引入了导致S639F替代或沉默同义突变的单个核苷酸变化。通过全基因组测序证实了EPIC系统的精确编辑。随后的敏感性测试表明,引入S639F突变会增加对棘白菌素的耐药性。此外,将野生型Fks1序列引入一个棘白菌素耐药的进化枝I临床分离株中,纠正突变,导致棘白菌素敏感性恢复。细胞壁组成评估显示,携带的分离株或菌株相对于同基因对照含有显著升高的β-葡聚糖和几丁质含量。
这些数据证明了我们的EPIC系统在多个进化枝背景下引入单核苷酸替代的能力,同时揭示了编码S639F突变对棘白菌素耐药性的直接影响。